Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10


Oral diacetylmorphine (heroin) yields greater morphine bioavailability than oral morphine: bioavailability related to dosage and prior opioid exposure.

Halbsguth U, Rentsch KM, Eich-Höchli D, Diterich I, Fattinger K.

Br J Clin Pharmacol. 2008 Dec;66(6):781-91. doi: 10.1111/j.1365-2125.2008.03286.x.


Identification of Borrelia burgdorferi ribosomal protein L25 by the phage surface display method and evaluation of the protein's value for serodiagnosis.

Mueller M, Bunk S, Diterich I, Weichel M, Rauter C, Hassler D, Hermann C, Crameri R, Hartung T.

J Clin Microbiol. 2006 Oct;44(10):3778-80.


Critical evaluation of urine-based PCR assay for diagnosis of Lyme borreliosis.

Rauter C, Mueller M, Diterich I, Zeller S, Hassler D, Meergans T, Hartung T.

Clin Diagn Lab Immunol. 2005 Aug;12(8):910-7.


Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage Lyme disease.

Schröder NW, Diterich I, Zinke A, Eckert J, Draing C, von Baehr V, Hassler D, Priem S, Hahn K, Michelsen KS, Hartung T, Burmester GR, Göbel UB, Hermann C, Schumann RR.

J Immunol. 2005 Aug 15;175(4):2534-40. Erratum in: J Immunol. 2006 May 1;176(9):5682.


G-CSF: boosting endogenous production--a new strategy?

von Aulock S, Diterich I, Hareng L, Hartung T.

Curr Opin Investig Drugs. 2004 Nov;5(11):1148-52. Review.


Granulocyte colony-stimulating factor (filgrastim) treatment primes for increased ex vivo inducible prostanoid release.

von Aulock S, Boneberg EM, Diterich I, Hartung T.

J Pharmacol Exp Ther. 2004 Feb;308(2):754-9. Epub 2003 Nov 10.


Borrelia burgdorferi-induced tolerance as a model of persistence via immunosuppression.

Diterich I, Rauter C, Kirschning CJ, Hartung T.

Infect Immun. 2003 Jul;71(7):3979-87.


Distribution of clinically relevant Borrelia genospecies in ticks assessed by a novel, single-run, real-time PCR.

Rauter C, Oehme R, Diterich I, Engele M, Hartung T.

J Clin Microbiol. 2002 Jan;40(1):36-43.


Borrelia burgdorferi s.l., the infectious agent of Lyme borreliosis.

Diterich I, Hartung T.

Contrib Microbiol. 2001;8:72-89. Review. No abstract available.


Modulation of cytokine release in ex vivo-stimulated blood from borreliosis patients.

Diterich I, Härter L, Hassler D, Wendel A, Hartung T.

Infect Immun. 2001 Feb;69(2):687-94.

Supplemental Content

Loading ...
Support Center